Phase III study (daNIS-2) of the antieTGF-β monoclonal antibody NIS793 with nab-paclitaxel/gemcitabine vs nab-paclitaxel/gemcitabine alone in patients with first-line metastatic pancreatic ductal adenocarcinoma Meeting Abstract
| Authors: | O'Reilly, E.; Golan, T.; Ikeda, M.; Milella, M.; Taieb, J.; Wainberg, Z.; Wang, L.; Gyambibi, N.; López, E.; Xu, K.; Macarulla, T. |
| Abstract Title: | Phase III study (daNIS-2) of the antieTGF-β monoclonal antibody NIS793 with nab-paclitaxel/gemcitabine vs nab-paclitaxel/gemcitabine alone in patients with first-line metastatic pancreatic ductal adenocarcinoma |
| Meeting Title: | ESMO 24th World Congress on Gastrointestinal Cancer 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2022 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | S254 |
| End Page: | S254 |
| Language: | English |
| ACCESSION: | WOS:000823826500036 |
| DOI: | 10.1016/j.annonc.2022.04.113 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P-22 -- Source: Wos |
